---
title: Crux Biolabs vs Swiss BioQuant AG
slug_a: cruxbiolabs
slug_b: swissbioquant
site: cro
review_signal_gate: closed
canonical_path: /compare/cruxbiolabs/swissbioquant
---

# Crux Biolabs vs Swiss BioQuant AG

Side-by-side profile data from each company listing on this directory.

## Crux Biolabs

- Profile: [/companies/cruxbiolabs](/companies/cruxbiolabs)

Crux Biolabs — Australia-based bioanalytical CRO offering small molecule LC-MS PK, ligand-binding large molecule PK, immunogenicity (ADA), biomarker, and flow cytometry assays for clinical programs. Services are delivered within an ISO/IEC 17025-accredited scope where applicable.

Services: 6. Modalities: 4. Indications: 4. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services

### Modalities

- Small Molecule
- Biologics (Other)
- Cell Therapy
- Vaccine

### Indications

- Oncology
- Immunology
- Metabolic
- Infectious Disease

### Phases

- Data not yet provided.

### Sourcing models

- Data not yet provided.

## Swiss BioQuant AG

- Profile: [/companies/swissbioquant](/companies/swissbioquant)

Swiss BioQuant AG — Bioanalytical CRO offering LC-MS/MS and ligand-binding assay development, validation, and sample analysis for small and large molecules. Work runs in a 21 CFR Part 11 compliant environment, with qPCR support for gene therapy bioanalysis.

Services: 6. Modalities: 6. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- In Vivo PK / PD Studies
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Peptide

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)

### Sourcing models

- Data not yet provided.